Mackenzie Financial Corp Buys 4,299 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Mackenzie Financial Corp boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 16.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,096 shares of the biopharmaceutical company’s stock after purchasing an additional 4,299 shares […]

Related Keywords

Canada ,Blackrock ,Nova Scotia ,William Blair ,Pushkal Garg ,Raymond James ,Sanfordc Bernstein ,Yvonne Greenstreet ,Alnylam Pharmaceuticals Inc ,News Ratings For Alnylam Pharmaceuticals Daily ,T Rowe Price Investment Management Inc ,Quarter For Alnylam Pharmaceuticals ,Nasdaq ,Mackenzie Financial Corp ,Geode Capital Management ,Blackrock Inc ,Vanguard Group Inc ,Alnylam Pharmaceuticals Stock Performance ,Royal Bank ,Securities Exchange Commission ,Alnylam Pharmaceuticals ,Free Report ,Financial Corp ,Rowe Price Investment Management ,Street Corp ,Capital Management ,Get Free Report ,Exchange Commission ,Visit Holdingschannel ,Alnylam Pharmaceuticals Daily ,Nasdaq Alny ,Dalny ,Medical ,02043q10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,